SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

What happens when you give Claude Code a blank webpage, and full control?

The Best Website Ever

The crypto asset BWE is trending negatively, with community sentiment focused on anticipated 'dumps' and shorting opportunities. Discussions include concerns about potential dilution, comparisons to a 'casino,' and broader anxieties related to market crashes and economic factors like tariffs and rate hikes.

SSgA Active Trust - Consumer Discretionary Select Sector SPDR

Consumer Discretionary Select Sector SPDR Fund

The Consumer Discretionary Select Sector SPDR Fund ($XLY) is trending as traders assess the strength of the consumer amid mixed signals. Recent data points, including retail sales and consumer confidence, are being weighed alongside potential impacts from tariffs and concerns about a slowing economy. Community discussion revolves around key support and resistance levels, as well as potential sector rotation and signals from related stocks like $TSLA and $AMZN.

Freeport-McMoRan, Inc. engages in the mining of copper, gold, and molybdenum. It operates through the following segments: North America Copper Mines, South America Operations, Indonesia Operations, Molybdenum Mines, Rod and Refining, Atlantic Copper Smelting and Refining, and Corporate and Other. The North America Copper Mines segment operates open-pit copper mines in Morenci, Bagdad, Safford, Sierrita, Miami in Arizona and Chino, and Tyrone in New Mexico. The South America Operations segment includes Cerro Verde in Peru and El Abra in Chile. The Indonesia Operations segment handles the operations of the Grasberg minerals district that produce copper concentrate containing significant quantities of gold and silver. The Molybdenum Mines segment includes the Henderson underground mine and Climax open pit mine, both in Colorado. The Rod and Refining segment consists of copper conversion facilities located in North America and includes a refinery and rod mills. The Atlantic Copper Smelting and Refining segment smelts and refines copper concentrate and markets refined copper and precious metals in slimes. The Corporate and Other segment offers other mining and eliminations, oil and gas operations, and other corporate and elimination items. The company was founded by James R. Moffett on November 10, 1987, and is headquartered in Phoenix, AZ.

Freeport-McMoRan Inc

FCX is trending as investors digest recent news, including revisions to Freeport's production outlook and analysts weighing in. Community discussions revolve around the impact of these factors on FCX's valuation and future prospects amid fluctuating copper prices and demand, while institutions increased their stakes.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is trending as the community discusses recent price action and its potential for an upcoming bull run, with some speculating about its quantum-resistant properties and the potential impact of new partnerships. The Folks Finance airdrop is also generating buzz, as users share their experiences with claiming tokens and discuss the DeFi landscape. Some traders believe a breakout is coming, while others remain skeptical about ALGO's long-term prospects.

CEL-SCI Corp. is a clinical-stage biotechnology company, which engages in the research, development, and manufacture of investigational immunotherapy products for the treatment of cancer and infectious diseases. Its product pipeline includes Multikine and Ligand Epitope Presentation System (LEAPS). Multikine is an investigational immunotherapy for the potential treatment of head and neck cancers. LEAPS is categorized into LEAPS-H1N1-DC, a product candidate for the treatment of pandemic influenza for hospitalized patients and CEL-2000 and CEL-4000, which are vaccine candidates for the treatment of rheumatoid arthritis. The company was founded by Maximilian de Clara on March 22, 1983 and is headquartered in Vienna, VA.

Cel-Sci Corp.

CVM is trending due to speculation surrounding the impending decision from the Saudi Food and Drug Authority regarding its application for Breakthrough Medicine Designation for Multikine, with the 60-day review period nearing its end. Community members are actively discussing the potential impact of a positive or negative outcome, including its effects on partnerships, revenue, and future trials. Disagreements and heated discussions among investors regarding the company's prospects and management add to the volatility.

Warner Bros. Discovery, Inc. is a premier global media and entertainment company, which engages in the provision of a differentiated portfolio of content, brands, and franchises across television, film, streaming, and gaming. It operates through the following segments: Studios, Networks, Direct-to-Consumer (DTC), and Corporate. The Studios segment includes producing and releasing feature films for initial exhibition in theaters, producing and initial licensing television programs to networks services as well as third parties, distributing films and television programs to various third party, internal television, and streaming services, distribution through the home entertainment market related consumer products, and themed experience licensing and interactive gaming. The Networks segment focuses on domestic and international television networks. The DTC segment is involved in premium pay-television and streaming services. The company was founded on June 17, 1985 and is headquartered in New York, NY.

Warner Bros. Discovery Inc - Ordinary Shares - Class A

Warner Bros Discovery Inc

WBD is trending amid speculation of a potential Netflix bid for its studio and streaming business, intensifying an existing acquisition buzz. Community chatter revolves around potential bidding wars and deal valuations, with some highlighting WBD's valuable IP while others are skeptical of its debt.  Comcast and Paramount/Skydance remain in the mix as possible suitors.

Kusama is a public blockchain network that is running the exact same codebase as Polkadot. It is aimed to be a canary build for the Polkadot network which is an experimental and development environment for new features that will eventually be deployed to Polkadot. Because of the experimental nature of Kusama, the developmental speed is much faster and it has seen significant traction since launched in 2019.  Kusama is an early, highly experimental version of Polkadot presenting real economic conditions. The community will own the network – there will be no central kill switch. Kusama will exist as long as its community maintains it and we envision it will cater to new, early functionality and projects preparing to develop and deploy on Polkadot.

Kusama 

Kusama is trending as traders discuss its potential for significant gains, drawing comparisons to Zcash's performance and past highs. The community is actively watching for a breakout above a key price level, anticipating a rapid surge. Discussions also mention the upcoming Polkadot and Kusama Network Migration.

BlackRock Institutional Trust Company N.A. - iShares U.S. Real Estate ETF

iShares US Real Estate ETF

The iShares US Real Estate ETF ($IYR) is trending as investors weigh the impact of rising rates and potential rate cuts on the real estate sector. Community discussions include concerns about commercial real estate weakness and potential breakdowns, while some traders point to insider buying and breakouts in specific real estate tech stocks. Divergence between gold and death cross indicators, along with comparisons to past housing market collapses, adds to the uncertain outlook.

ETFis Series Trust I - Virtus LifeSci Biotech Clinical Trials ETF

Biotech stocks are rallying, with $BBC hitting a 52-week high, as optimism around regulatory approvals, potential rate cuts, and attractive valuations fuel sector-wide momentum. Community members are noting new highs and large volume, while also cautioning appropriate position sizing given the volatility of binary events. The ETF's positive weighted alpha and sector tailwinds are also key discussion points.

eCash (XEC) is a Layer-1 digital cash network, developed by Bitcoin ABC. It was created on Nov 15th, 2020, and has since distinguished itself from its predecessors and other Bitcoin clients by integrating the breakthrough Avalanche consensus with its core proof-of-work (PoW) layer, extending its security and fundamental capabilities.  This hybrid consensus integration gives it unique properties for a Bitcoin-like chain, such as interoperability, staking rewards, real-time processing, and an improved overall extensibility, which is hard to achieve in a completely trustless manner using only Nakamoto consensus.  The development roadmap is set with three main goals: Scaling transaction throughput from ~100 tps to more than 5.000.000 tps Improving the payment experience with a less than 3 second transaction finality time Extending the protocol and establishing fork-free upgrade routines, allowing for more rapid, iterative development

eCash

eCash ($XEC) is trending due to anticipation surrounding its upcoming network upgrade on November 15, which includes Avalanche Pre-Consensus. The community is excited about the promise of instant finality and faster transaction processing that the upgrade is expected to bring to the peer-to-peer digital cash system. Several exchanges have also announced support for the upgrade.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Jackson Square Partners LLC Cuts Stock Position in Axcelis Technologies, Inc. $ACLS

Jackson Square Partners LLC lowered its holdings in Axcelis Technologies, Inc. (NASDAQ:ACLS - Free Report) by 83.3% in the second quarter, according to its most recent disclosure with the SEC. The...

DA Davidson Has Bullish Forecast for ACLS FY2026 Earnings

Axcelis Technologies, Inc. (NASDAQ:ACLS - Free Report) - Stock analysts at DA Davidson upped their FY2026 earnings per share (EPS) estimates for Axcelis Technologies in a report issued on Wednesday...

B. Riley Research Analysts Lift Earnings Estimates for ACLS

Axcelis Technologies, Inc. (NASDAQ:ACLS - Free Report) - Equities researchers at B. Riley raised their Q2 2026 earnings per share estimates for shares of Axcelis Technologies in a research note...

Research Analysts Offer Predictions for ACLS Q2 Earnings

Axcelis Technologies, Inc. (NASDAQ:ACLS - Free Report) - Research analysts at William Blair raised their Q2 2026 earnings per share estimates for Axcelis Technologies in a research report issued on...

Axcelis Technologies (NASDAQ:ACLS) Posts Earnings Results, Beats Estimates By $0.20 EPS

Axcelis Technologies (NASDAQ:ACLS - Get Free Report) posted its quarterly earnings results on Tuesday. The semiconductor company reported $1.21 earnings per share (EPS) for the quarter, beating the...

Axcelis Technologies (NASDAQ:ACLS) Given New $84.00 Price Target at B. Riley

B. Riley dropped their target price on shares of Axcelis Technologies from $85.00 to $84.00 and set a "neutral" rating on the stock in a research report on Wednesday...

All You Need to Know About Axcelis (ACLS) Rating Upgrade to Buy

Axcelis (ACLS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Axcelis Announces Participation in Upcoming Investor Conferences

Axcelis Announces Participation in Upcoming Investor Conferences Axcelis Announces Participation in Upcoming Investor Conferences PR Newswire BEVERLY, Mass., Nov. 6, 2025 BEVERLY, Mass., Nov. 6, 2025...

Axcelis Technologies (ACLS) Q3 Earnings and Revenues Surpass Estimates

Axcelis (ACLS) delivered earnings and revenue surprises of +19.80% and +6.65%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Axcelis Announces Financial Results for Third Quarter 2025

Axcelis Announces Financial Results for Third Quarter 2025 Axcelis Announces Financial Results for Third Quarter 2025 PR Newswire BEVERLY, Mass., Nov. 4, 2025 Q3 Highlights: Revenue of $213.6...

Axcelis Technologies, Inc. engages in the manufacture of capital equipment for the semiconductor chip manufacturing industry. Its ion implantation systems product line includes high and medium current, and energy implanters. It also offers post-sales equipment service and support, such as spare parts, equipment upgrades, used equipment, maintenance services, and customer training. The company was founded in 1978 and is headquartered in Beverly, MA.

Axcelis Technologies Inc

$ASTS

$RKLB

$BBAI

$NBIS

Which earnings release are you most excited for the week of Nov. 10? 
 
Drop a comment for others.

Current Price	$85.74
Prev Close	$82.14
Open	$80.54
Dividend Yield	0.00%
50-Day Moving Average	$86.28
Beta	1.87
Avg. Volume	772,668.13
PE Ratio	20.25

52-Week High	$102.93
52-Week Low	$40.40
Market Capitalization	$2.66B
EPS (Annual)	$6.15
Price to Book	2.61
Revenue Per Employee	$667,890.42
Enterprise Value/EBITDA	N/A

ACLS
Axcelis Technologies Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ACLS News

ACLSAxcelis Technologies Inc